Why Recent IPO Aimmune Therapeutics Could Rise 50% to 100%
24/7 Wall St. has chosen two key analysts to highlight that have issued calls on Aimmune.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 250Is the Move in Vital Therapies Sustainable?
Vital Therapies made a big run in the market on Monday morning following additional data from the 16th International Symposium on Albumin Dialysis in Liver Disease.
The Medicines Company and Alnylam Rise on Positive Phase 1 Results
Alnylam Pharmaceuticals and The Medicines Company made waves Monday morning despite downward pressure from the broad markets.
Canadian Cannabis Firms Close Merger
Tweed Marijuana announced Monday morning that the company had completed its merger with Bedrocan Cannabis.
5 Big FDA Decisions Expected in September
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of September and added some color.
How Amgen Can Disrupt the Market for Cholesterol Drugs
Amgen has the potential to disrupt the market for cholesterol drugs with the newest addition to its drug portfolio.
Acelity Files for Initial Public Offering
Acelity Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Short Sellers Become More Focused in Major Biotechs
The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks.
Short Sellers Have Mixed Feelings on Major Pharma
The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
Mylan Fires Back at Perrigo
Mylan announced Tuesday, in conjunction with the Irish Takeover Panel, that Perrigo had made misleading statements to shareholders.
Nabriva Files for IPO
Nabriva Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Mirna Therapeutics Files for IPO
Mirna Therapeutics has filed with the Securities and Exchange Commission (SEC) to conduct an initial public offering (IPO).
2 Positive Health Care REIT Views
Physicians Realty Trust and Health Care REIT were both given positive analyst views by the analyst team at Canaccord Genuity.
Epizyme Beats Out the Market With FDA Approval
Epizyme survived the market carnage of Monday morning’s trading session. In fact this biopharma came out of the fray better off than when it went in.
HMS Runs on State of New York Contract
ThinkstockHMS Holdings Corp. (NASDAQ: HMSY) is winning in the market Monday despite all the turmoil and volatility that tanked the market earlier. Only recently did this company reported earnings at the tail end of…